Acorah Software Products - Accounts Production16.4.675falsetruefalsetrueNo description of principal activity11 January 202431 January 202531 January 202515409453Mr Paul RobinsonMrs Rona Robinsoniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure154094532024-01-10154094532025-01-31154094532024-01-112025-01-3115409453frs-core:CurrentFinancialInstruments2025-01-3115409453frs-bus:PrivateLimitedCompanyLtd2024-01-112025-01-3115409453frs-bus:FilletedAccounts2024-01-112025-01-3115409453frs-bus:Micro-entities2024-01-112025-01-3115409453frs-bus:AuditExempt-NoAccountantsReport2024-01-112025-01-3115409453frs-bus:Director12024-01-112025-01-3115409453frs-bus:Director22024-01-112025-01-31
Registered number: 15409453
PJR Pharma Ltd
Unaudited Financial Statements
For the Period 11 January 2024 to 31 January 2025
PJR Pharma Ltd
Balance Sheet
As At 31 January 2025
Balance Sheet
Registered number: 15409453
31 January 2025
£
Fixed assets
2,048
Current assets
37,045
Creditors: Amounts Falling Due Within One Year
(9,499)
NET CURRENT ASSETS
27,546
TOTAL ASSETS LESS CURRENT LIABILITIES
29,594
NET ASSETS
29,594
CAPITAL AND RESERVES
29,594
Notes
1.General Information
PJR Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15409453. The registered office is 8 Heddon Court Avenue, Barnet, London, EN4 9NE.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.